In silico analysis and theratyping of an ultra-rare CFTR genotype (W57G/A234D) in primary human rectal and nasal epithelial cells.

Autor: Kleinfelder K; Department of Medicine, University of Verona, Division of General Pathology, 37134 Verona, Italy., Lotti V; Department of Medicine, University of Verona, Division of General Pathology, 37134 Verona, Italy., Eramo A; Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, 00161 Rome, Italy., Amato F; Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, 80131 Naples, Italy.; CEINGE-Biotecnologie Avanzate Franco Salvatore S.c.a.r.l., 80145 Naples, Italy., Lo Cicero S; Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, 00161 Rome, Italy., Castelli G; Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, 00161 Rome, Italy., Spadaro F; Confocal Microscopy Unit, Core Facilities, Istituto Superiore di Sanità, 00161 Rome, Italy., Farinazzo A; Department of Medicine, University of Verona, Division of General Pathology, 37134 Verona, Italy., Dell'Orco D; Department of Neurosciences, Biomedicine and Movement Sciences, Section of Biological Chemistry, University of Verona, 37134 Verona, Italy., Preato S; Department of Medicine, University of Verona, Division of General Pathology, 37134 Verona, Italy., Conti J; Department of Medicine, University of Verona, Division of General Pathology, 37134 Verona, Italy., Rodella L; Endoscopic Surgery Unit, Azienda Ospedaliera Universitaria Integrata Verona, 37126 Verona, Italy., Tomba F; Endoscopic Surgery Unit, Azienda Ospedaliera Universitaria Integrata Verona, 37126 Verona, Italy., Cerofolini A; Endoscopic Surgery Unit, Azienda Ospedaliera Universitaria Integrata Verona, 37126 Verona, Italy., Baldisseri E; Cystic Fibrosis Centre, Azienda Ospedaliera Universitaria Integrata Verona, 37126 Verona, Italy., Bertini M; Cystic Fibrosis Centre, Azienda Ospedaliera Universitaria Integrata Verona, 37126 Verona, Italy., Volpi S; Cystic Fibrosis Centre, Azienda Ospedaliera Universitaria Integrata Verona, 37126 Verona, Italy., Villella VR; Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, 80131 Naples, Italy.; CEINGE-Biotecnologie Avanzate Franco Salvatore S.c.a.r.l., 80145 Naples, Italy., Esposito S; Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, 80131 Naples, Italy.; CEINGE-Biotecnologie Avanzate Franco Salvatore S.c.a.r.l., 80145 Naples, Italy., Zollo I; Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, 80131 Naples, Italy.; CEINGE-Biotecnologie Avanzate Franco Salvatore S.c.a.r.l., 80145 Naples, Italy., Castaldo G; Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, 80131 Naples, Italy.; CEINGE-Biotecnologie Avanzate Franco Salvatore S.c.a.r.l., 80145 Naples, Italy., Laudanna C; Department of Medicine, University of Verona, Division of General Pathology, 37134 Verona, Italy., Sorsher EJ; Department of Pediatrics, Division of Pulmonary, Allergy/Immunology, Cystic Fibrosis & Sleep, Emory University, Atlanta, GA 30322, USA., Hong J; Department of Pediatrics, Division of Pulmonary, Allergy/Immunology, Cystic Fibrosis & Sleep, Emory University, Atlanta, GA 30322, USA., Joshi D; Department of Pediatrics, Division of Pulmonary, Allergy/Immunology, Cystic Fibrosis & Sleep, Emory University, Atlanta, GA 30322, USA., Cutting G; McKusick-Nathans Department of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA., Lucarelli M; Department of Experimental Medicine, Sapienza University of Rome, 00185 Rome, Italy.; Pasteur Institute, Cenci Bolognetti Foundation, Sapienza University of Rome, 00161 Rome, Italy., Melotti P; Cystic Fibrosis Centre, Azienda Ospedaliera Universitaria Integrata Verona, 37126 Verona, Italy., Sorio C; Department of Medicine, University of Verona, Division of General Pathology, 37134 Verona, Italy.

Publikováno v: IScience [iScience] 2023 Oct 12; Vol. 26 (11), pp. 108180. Date of Electronic Publication: 2023 Oct 12 (Print Publication: 2023).

Corrigendum: Age-Related Differences in the Expression of Most Relevant Mediators of SARS-CoV-2 Infection in Human Respiratory and Gastrointestinal Tract (Front. Pediatr., (2021), 9, (697390), 10.3389/fped.2021.697390)

Autor: Berni Canani R., Comegna M., Paparo L., Cernera G., Bruno C., Strisciuglio C., Zollo I., Gravina A. G., Miele E., Cantone E., Gennarelli N., Nocerino R., Carucci L., Giglio V., Amato F., Castaldo G.

In the original article, there was a mistake in the order of Figures 1 and 2 as published. The figures are given in the correct order below. The authors apologize for the error and state that this does not change the scientific conclusions of the art

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3730::000b1a5303760dfdbc3fbae860adb653
http://hdl.handle.net/11588/878670

L1077P CFTR pathogenic variant function rescue by Elexacaftor-Tezacaftor-Ivacaftor in cystic fibrosis patient-derived air-liquid interface (ALI) cultures and organoids: in vitro guided personalized therapy of non-F508del patients.

Autor: Lo Cicero S; Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy., Castelli G; Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy., Blaconà G; Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy., Bruno SM; Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy., Sette G; Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy., Pigliucci R; Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy., Villella VR; Department of Molecular Medicine and Medical Biotechnologies, University of Naples Federico II, Naples, Italy.; CEINGE-Biotecnologie Avanzate S.c.a.r.l, Naples, Italy., Esposito S; Department of Molecular Medicine and Medical Biotechnologies, University of Naples Federico II, Naples, Italy.; CEINGE-Biotecnologie Avanzate S.c.a.r.l, Naples, Italy., Zollo I; Department of Molecular Medicine and Medical Biotechnologies, University of Naples Federico II, Naples, Italy.; CEINGE-Biotecnologie Avanzate S.c.a.r.l, Naples, Italy., Spadaro F; Confocal Microscopy Unit, Core Facilities, Istituto Superiore di Sanità, Rome, Italy., Maria R; Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy.; Fondazione Policlinico Universitario 'A. Gemelli'-IRCCS, Rome, Italy., Biffoni M; Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy., Cimino G; Cystic Fibrosis Reference Center of Lazio Region, AOU Policlinico Umberto I, Rome, Italy., Amato F; Department of Molecular Medicine and Medical Biotechnologies, University of Naples Federico II, Naples, Italy.; CEINGE-Biotecnologie Avanzate S.c.a.r.l, Naples, Italy., Lucarelli M; Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy.; Pasteur Institute, Cenci Bolognetti Foundation, Sapienza University of Rome, Rome, Italy., Eramo A; Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy. adriana.eramo@iss.it.

Publikováno v: Respiratory research [Respir Res] 2023 Sep 06; Vol. 24 (1), pp. 217. Date of Electronic Publication: 2023 Sep 06.

The Immune Response to SARS-CoV-2 Vaccine in a Cohort of Family Pediatricians from Southern Italy.

Autor: Cortese P; Federazione Italiana Medici Pediatri (FIMP), 80142 Naples, Italy., Amato F; Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università di Napoli Federico II, 80131 Naples, Italy.; CEINGE Biotecnologie Avanzate Franco Salvatore, Scarl, 80131 Naples, Italy., Davino A; Federazione Italiana Medici Pediatri (FIMP), 80142 Naples, Italy., De Franchis R; Federazione Italiana Medici Pediatri (FIMP), 80142 Naples, Italy., Esposito S; CEINGE Biotecnologie Avanzate Franco Salvatore, Scarl, 80131 Naples, Italy., Zollo I; Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università di Napoli Federico II, 80131 Naples, Italy.; CEINGE Biotecnologie Avanzate Franco Salvatore, Scarl, 80131 Naples, Italy., Di Domenico M; Dipartimento di Medicina di Precisione, Università degli Studi della Campania Luigi Vanvitelli, 80138 Naples, Italy., Solito E; Centre for Translational Medicine and Therapeutics William Harvey Research Institute, Queen Mary Univesity, London E1 4NS, UK., Zarrilli F; Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università di Napoli Federico II, 80131 Naples, Italy.; CEINGE Biotecnologie Avanzate Franco Salvatore, Scarl, 80131 Naples, Italy., Gentile L; CEINGE Biotecnologie Avanzate Franco Salvatore, Scarl, 80131 Naples, Italy., Cernera G; Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università di Napoli Federico II, 80131 Naples, Italy.; CEINGE Biotecnologie Avanzate Franco Salvatore, Scarl, 80131 Naples, Italy., Castaldo G; Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università di Napoli Federico II, 80131 Naples, Italy.; CEINGE Biotecnologie Avanzate Franco Salvatore, Scarl, 80131 Naples, Italy.

Publikováno v: Cells [Cells] 2023 May 23; Vol. 12 (11). Date of Electronic Publication: 2023 May 23.

623 Preliminary assessment of nasal and colon-derived primary cells theratyping for a personalized medicine approach in people with cystic fibrosis carrying ultra-rare genotypes

Autor: Sorio, C., Kleinfelder, K., Amato, F., Conti, J., Lotti, V., Farinazzo, A., Baldisseri, E., Bertini, M., Volpi, S., Eramo, A., Cicero, S.O., Lucarelli, M., Villella, V., Zollo, I., Castaldo, G., Melotti, P.

Publikováno v: In Journal of Cystic Fibrosis October 2022 21 Supplement 2:S344-S344